Remove 2008 Remove Access Remove Conditions Remove Microdosing
article thumbnail

Research Shows Strong Support for Natural Therapeutics

Veriheal

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy.

Therapy 98
article thumbnail

Oregon is Setting the Foundation for its Psilocybin Therapy Program

Veriheal

The campaign manager of the ‘Yes on 109’ campaign that helped see the measure passed, Sam Chapman, told media sources, “There’s a huge breadth of expertise on this board from harm reduction experts to folks that have experience working with different populations that stand to benefit from having access to psilocybin therapy.

Therapy 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Here’s What Neuroimaging Can Tell Us About the Psychedelic Experience

SpeedWeed

Feduccia 2008): Ph.D. In her study published in the April 2020 issue of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging , Bershad wanted to investigate the recent trend of microdosing LSD and analyze if there’s any scientific merit to the practice. Here are just a few interesting research studies. researcher Allison A.

article thumbnail

UW-Madison Is Diversifying Psychedelic Research

Veriheal

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy.

Therapy 98
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Paul is the author of the book Microdosing Psychedelics: A Practical Guide to Upgrade Your Life and the founder and CEO of Third Wave and co-founder of Synthesis.